id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-3758-0003,FDA,FDA-2018-N-3758,"Attachment 1 - Form FDA 3926 – Individual Patient Expanded Access, Investigational New Drug Application (IND) re: Agency Information Collection Activities; Proposed Collection; Comment Request; Individual Patient Expanded Access Applications: Form FDA 3926",Supporting & Related Material,Background Material,2018-11-14T05:00:00Z,2018,11,,,2018-11-15T03:25:00Z,,0,0,09000064838d8ade
FDA-2018-N-3758-0004,FDA,FDA-2018-N-3758,Attachment 2 - Form Instructions re: Agency Information Collection Activities; Proposed Collection; Comment Request; Individual Patient Expanded Access Applications: Form FDA 3926,Supporting & Related Material,Background Material,2018-11-14T05:00:00Z,2018,11,,,2018-11-15T03:25:09Z,,0,0,09000064838d8adf
FDA-2018-N-3758-0002,FDA,FDA-2018-N-3758,"Individual Patient Expanded Access Applications: Form FDA 3926
Guidance for Industry",Other,Guidance,2018-11-14T05:00:00Z,2018,11,2018-11-14T05:00:00Z,,2024-11-12T22:49:51Z,,1,0,09000064838d805a
FDA-2018-N-3758-0001,FDA,FDA-2018-N-3758,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Individual Patient Expanded Access Applications: Form FDA 3926",Notice,60 Day Proposed Information Collection,2018-11-07T05:00:00Z,2018,11,2018-11-07T05:00:00Z,2019-01-08T04:59:59Z,2018-11-07T15:20:25Z,2018-24321,0,0,09000064838a7b1c